Growth hormone
Increase · large
Stimulates pituitary GH release
Literature evidence
Compound library
Vivy evidence dossier
Human Growth Hormone (HGH)
Also indexed as Somatropin, HGH, Recombinant human growth hormone, rHGH
T1Peptides
Read this entry as context, not instruction.
Evidence labels describe the material available in this reference entry. They do not establish that a compound is appropriate, effective, or safe for you. Inclusion is not a recommendation to use it.
Reference context
Pharmacokinetic context
Half-life3.5 hr
This field summarizes the library record. Half-life can vary with formulation, indication, and individual clinical context.
Observed relationships
Biomarker context
IGF-1
Increase · large
GH/IGF-1 axis activation
Literature evidence
IGFBP-3
Increase · moderate
GH-mediated binding proteins
Literature evidence
Keep in view
Safety discussion points
HGH (somatropin) is FDA-approved for growth hormone deficiency, Turner syndrome, and other conditions. Recombinant HGH widely used. Supraphysiological doses for anti-aging are off-label.
Keep the reference close
Track Human Growth Hormone (HGH) in context.
Hey Vivy helps you organize protocols and review change over time. It does not diagnose, prescribe, or replace qualified care.